Dr. Robert J. Gould has made notable insider trades at Fulcrum Therapeutics, peaking at $14.15 million in September 2021. His trading activity suggests confidence in the company's prospects, although his holdings have seen considerable fluctuation. After a series of high-value...

Dr. Robert J. Gould has made notable insider trades at Fulcrum Therapeutics, peaking at $14.15 million in September 2021. His trading activity suggests confidence in the company's prospects, although his holdings have seen considerable fluctuation. After a series of high-value transactions in early 2020, his activity trended lower in the following years, with notable declines in 2022 and a brief resurgence in early 2023 before tapering off. As of late 2023, Dr. Gould’s trading volume reflected a considerable downward trend, indicating a more cautious approach in response to market conditions. This shift shows a strategic approach to managing personal investments while still being invested in the company's trajectory.